Three new board members for Bacterin
This article was originally published in Clinica
Executive Summary
Bioactive coating specialist Bacterin International has appointed three "seasoned financial experts" to its board of directors: Daniel Frank, Gary Simon and Ken Calligar. Mr Frank has 31 years of asset management experience with a focus on the healthcare industry. He has served on several company boards including stent developer Reva Medical and point-of-care testing firm i-STAT. Mr Simon is currently a manager of UVE Partners, an investment fund that he co-founded. Before this, he was senior vice-president of investment banking firm Barington Capital Group. Mr Calligar is the founder and managing partner of investment banking firm Convertible Capital, and was previously a managing director of Jefferies & Co. He has over 25 years' experience in the financial industry. Belgrade, Montana-based Bacterin develops coatings for medical devices, transplants and tissue products.